Castle Biosciences (NASDAQ:CSTL) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Castle Biosciences beat estimated earnings by 46.81%, reporting an EPS of $-0.25 versus an estimate of $-0.47.
Revenue was up $7.74 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.07 which was followed by a 10.19% drop in the share price the next day.
Here's a look at Castle Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.37 | -0.24 | -0.12 |
| EPS Actual | -0.47 | -0.34 | -0.17 | -0.17 |
| Revenue Estimate | 22.97M | 18.93M | 16.66M | 15.74M |
| Revenue Actual | 23.48M | 22.76M | 22.81M | 17.30M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
